Erythromycin Blocks the Rapid Component of the Delayed Rectifier Potassium Current and Lengthens Repolarization of Guinea Pig Ventricular Myocytes
- 15 June 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 91 (12) , 3010-3016
- https://doi.org/10.1161/01.cir.91.12.3010
Abstract
Background Administration of erythromycin to humans has been associated with lengthening of cardiac repolarization and even proarrhythmia. The objectives of our study were to describe effects of erythromycin on repolarization of isolated hearts and to determine effects of the drug on major K + currents involved in cardiac repolarization. Methods and Results A first set of experiments was conducted in isolated, buffer-perfused guinea pig hearts electrically stimulated at a basic cycle length of 250 ms. In this model, erythromycin 10 −4 mol/L increased monophasic action potential duration measured at 90% repolarization (MAPD 90 ) by 40±7 ms. Increase in MAPD 90 was reproducibly observed in seven hearts studied. To study the mechanism of these effects on cardiac repolarization, a second set of experiments was performed in isolated guinea pig ventricular myocytes using the whole cell configuration of the patch-clamp technique. In these cells, erythromycin 10 −4 mol/L decreased by about 40% ( P <.05 versus baseline) the time-dependent outward K + current elicited by short depolarizations (250 ms) to low depolarizing voltages (−20 to 0 mV). In contrast, the drug was without significant effects on the time-dependent K + current elicited by long pulses (5000 ms) to high depolarizing voltages (+10 to +50 mV), on the time-independent background current (mostly I K1 ), and on the slow inward calcium current. Conclusions The outward time-dependent K + current blocked by erythromycin in isolated guinea pig ventricular myocytes had characteristics similar to those described for I Kr . Selective block of this component of I K gives an explanation for the effects of erythromycin on cardiac repolarization. These effects were observed at clinically relevant concentrations reached after intravenous administration of the drug and warn for potential interactions with other action potential–lengthening drugs.Keywords
This publication has 15 references indexed in Scilit:
- Erythromycin-Induced QT Prolongation and Polymorphic Ventricular Tachycardia (Torsades de Pointes): Case Report and ReviewClinical Infectious Diseases, 1994
- Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome.Circulation, 1993
- Cardiac toxicity associated with intravenous erythromycin lactobionateThe Pediatric Infectious Disease Journal, 1993
- A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell.Circulation Research, 1991
- A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivoJournal of the American College of Cardiology, 1990
- Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.The Journal of general physiology, 1990
- Rate dependence of action potential duration and refractoriness in canine ventricular endocardium differs from that of epicardium: Role of the transient outward currentJournal of the American College of Cardiology, 1989
- Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndromeThe American Journal of Cardiology, 1987
- QT prolongation and recurrent “torsades de pointes” during erythromycin lactobionate infusionThe American Journal of Cardiology, 1986
- Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycinThe American Journal of Cardiology, 1984